New ADHD Drug Subsidized, Australia
Main Category: ADHDArticle Date: 17 Apr 2007 - 6:00 PDT
email to a friend 
printer friendly 
opinions
| Patient / Public: |  |
3 (5 votes) |
| Healthcare Prof: |  |
3.14 (7 votes) |
| Article Opinions: | 2 posts |
A new drug for the treatment of attention deficit hyperactivity disorder (ADHD) will be listed from 1 July 2007 on the Pharmaceutical Benefits Scheme (PBS).
The drug, Strattera® (atomoxetine), will provide treatment for children between the ages of six and 18 years who cannot take stimulants.
ADHD is a behavioural and developmental disorder that affect young children. The main symptoms of ADHD - inattention, hyperactivity and impulsivity - contribute to adverse academic and social behaviour, which can have consequences that persist throughout adolescence and into adulthood.
Treatment for ADHD normally involves stimulant therapy, so the listing of Strattera® on the PBS will especially benefit those who are unable to take stimulants.
About 18,000 people will commence Strattera® in the first full financial year of listing.
The listing of Strattera® will add around $101.2 million to PBS and Repatriation Pharmaceutical Benefits Scheme expenditure between 2007-08 and 2010-11.
www.health.gov.au
Visit our adhd section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/68063.php>
APA
http://www.medicalnewstoday.com/releases/68063.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (2)
Strattera And Prozac Are The Same SSRI's
posted by Fernand Haesbrouck on 28 May 2007 at 6:48 amThe active metabolite of Strattera is the same active metabolite as Prozac.
See : http://www.haesbrouck.be/strattera_amfetamine.jpg
When both products where metabolised by digestion, both active phenylpropylamines acts in a similar way as the amphetamines act.
Amphetamines are chemically close to these new SSRI’s because their chemical structure are phenethylamines.
Because of the difference of that one C-Atom between phenylethylamines and phenylproylamines, dosages are adapted: amphetamine-pills are at 5mg , prozac-pills at 20-60 mg.
As the result, both are working in the same way: destroying neurons to inhibit control over the nervous system and causing symptoms of hallucination on a long term use.
I described the working mechanism of ADHD-medication in my book ( for this moment only available in Dutch) : “ADHD-medicatie: medische megablunder”, ISBN: 978-90902173-3.
http://www.haesbrouck.be
http://www.megablunder.net
Strattera is not the same as SSRI's
posted by Dr A on 28 Dec 2010 at 2:24 amIt looks like you got this one wrong.
SRRI's are selective to seretonin uptake transports. They only increase the amount of seretonin. No effect on Noradrenaline/norepinephrine.
Strattera is selective to noradrenaline. They increase the amount of noradrenaline in the synaptic cleft. Thus you get the 'stimulant' effect. No or very very little effect on seretonin
Both don't destroy neurons. Where do you get your information from may I ask?
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
